Dr. Bajarang Kumbhar is a computational structural biologist. He has done internationally acclaimed research on the anti-mitotic drug resistance in various carcinomas, the design of Chimeric Antigen Receptors (CAR) for cancer immunotherapy, and the role of modified nucleosides in the protein biosynthesis process. He has expertise in molecular modeling techniques, which include protein modeling, docking, molecular dynamics simulations, high-throughput drug screening, etc.